Literature DB >> 31792900

Gastric Per Oral Pyloromyotomy for Post-Vagotomy-Induced Gastroparesis Following Esophagectomy.

Mark J Anderson1, Megan Sippey, Jeffrey Marks.   

Abstract

BACKGROUND: Following the success of per-oral endoscopic myotomy (POEM) for achalasia, application of this minimally invasive skillset has broadened to other disease processes. Since 2013, gastric per-oral pyloromyotomy (GPOP) has become an increasingly accepted therapy for refractory gastroparesis. Although it does not treat the underlying etiology of the disease, pyloromyotomy has demonstrated measurable improvements in gastric emptying scintigraphy, nausea, and quality of life. Gastroparesis is a common complication of esophagectomy due to the inherent vagotomy that occurs during creation of the gastric conduit. Fifteen to 30% of post-esophagectomy patients develop gastroparesis with a large portion of them reporting symptoms refractory to medical therapy, botox injection, and endoscopic dilation. Therefore, GPOP may have the potential to offer symptomatic relief to a significant population of debilitated post-esophagectomy patients.
MATERIALS AND METHODS: The procedure was recorded using standard operating room equipment. Materials utilized included high-definition single-channel gastroscope, therapeutic overtube, clear endoscopic cap, triangle tip (TT) knife, ERBE energy source, endoscopic clips, sclerotherapy needle, methylene blue with epinephrine, and CO2 insufflator.
RESULTS: We present a video of GPOP for a 71-year-old male with post-vagotomy-induced gastroparesis after esophagectomy. His pre-operative course was significant for persistent nausea and vomiting, diet intolerance, 20 lb weight loss, and frequent hospitalizations for aspiration pneumonia. Post-operatively, the patient recovered well and was discharged home on post-operative day 1 on a liquid diet. At 3-week follow-up, his nausea, vomiting, and PO intolerance had improved. At 6-month follow-up, he had no recent admissions for aspiration pneumonia and his pylorus remained widely patent on EGD.
CONCLUSIONS: GPOP status post-esophagectomy presented multiple challenges: difficulty maintaining field of view and insufflation, establishing tension and counter tension for the mucosotomy, and a limited working space. With care and patience, endoscopists trained to perform POEM may apply their skillset to help a large population of patients suffering with post-esophagectomy gastroparesis.

Entities:  

Keywords:  POEM; POP; endoscopic pyloromyotomy; esophagectomy; gastroparesis; per-oral pyloromyotomy

Mesh:

Year:  2019        PMID: 31792900     DOI: 10.1007/s11605-019-04418-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  10 in total

1.  Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video).

Authors:  Mouen A Khashab; Ellen Stein; John O Clarke; Payal Saxena; Vivek Kumbhari; Bani Chander Roland; Anthony N Kalloo; Stavros Stavropoulos; Pankaj Pasricha; Haruhiro Inoue
Journal:  Gastrointest Endosc       Date:  2013-11       Impact factor: 9.427

2.  A decade analysis of trends and outcomes of partial versus total esophagectomy in the United States.

Authors:  Mehraneh D Jafari; Wissam J Halabi; Brian R Smith; Vinh Q Nguyen; Michael J Phelan; Michael J Stamos; Ninh T Nguyen
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

3.  Novel and validated approaches for gastric emptying scintigraphy in patients with suspected gastroparesis.

Authors:  Michael Camilleri; Andrea Shin
Journal:  Dig Dis Sci       Date:  2013-05-22       Impact factor: 3.199

4.  Comparison of pyloric intervention strategies at the time of esophagectomy: is more better?

Authors:  Mara B Antonoff; Varun Puri; Bryan F Meyers; Kevin Baumgartner; Jennifer M Bell; Stephen Broderick; A Sasha Krupnick; Daniel Kreisel; G Alexander Patterson; Traves D Crabtree
Journal:  Ann Thorac Surg       Date:  2014-04-21       Impact factor: 4.330

5.  Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement.

Authors:  Michael L Hibbard; Christy M Dunst; Lee L Swanström
Journal:  J Gastrointest Surg       Date:  2011-07-01       Impact factor: 3.452

6.  G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome.

Authors:  J M Gonzalez; A Benezech; V Vitton; M Barthet
Journal:  Aliment Pharmacol Ther       Date:  2017-05-15       Impact factor: 8.171

7.  Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video).

Authors:  Mouen A Khashab; Saowanee Ngamruengphong; David Carr-Locke; Amol Bapaye; Petros C Benias; Sam Serouya; Shivangi Dorwat; Dalton M Chaves; Everson Artifon; Eduardo G de Moura; Vivek Kumbhari; Yamile Haito Chavez; Majidah Bukhari; Gulara Hajiyeva; Amr Ismail; Yen-I Chen; Hyunsoo Chung
Journal:  Gastrointest Endosc       Date:  2016-06-25       Impact factor: 9.427

Review 8.  Functional conduit disorders after esophagectomy.

Authors:  Jessica Scott Donington
Journal:  Thorac Surg Clin       Date:  2006-02       Impact factor: 1.750

9.  Per oral endoscopic pyloromyotomy for refractory gastroparesis: initial results from a single institution.

Authors:  John H Rodriguez; Ivy N Haskins; Andrew T Strong; Ryan L Plescia; Matthew T Allemang; Robert S Butler; Michael S Cline; Kevin El-Hayek; Jeffrey L Ponsky; Matthew D Kroh
Journal:  Surg Endosc       Date:  2017-05-31       Impact factor: 4.584

10.  Early human experience with per-oral endoscopic pyloromyotomy (POP).

Authors:  Eran Shlomovitz; Radu Pescarus; Maria A Cassera; Ahmed M Sharata; Kevin M Reavis; Christy M Dunst; Lee L Swanström
Journal:  Surg Endosc       Date:  2014-08-09       Impact factor: 4.584

  10 in total
  1 in total

Review 1.  Functional syndromes and symptom-orientated aftercare after esophagectomy.

Authors:  Kristjan Ukegjini; Diana Vetter; Rebecca Fehr; Valerian Dirr; Christoph Gubler; Christian A Gutschow
Journal:  Langenbecks Arch Surg       Date:  2021-05-25       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.